Fidelity Investments’s Allarity Therapeutics ALLR Stock Holding History

Fidelity Investments’s Portfolio ALLR Stock Details ALLR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17	Buy	+13	New	+$18	﹤0.01%	5513

Other funds holding ALLR

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MCM

Militia Capital Management Austin, Texas $3.37B AUM

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Fidelity Investments's ALLR Position: Q2 2026 in Review

Fidelity Investments opened a new position in Allarity Therapeutics (ALLR) in Q2 2026: 13 shares worth $17. The stake represents ﹤0.01% of the portfolio and ranks #5513 among its holdings.

20 funds tracked by Wall St. Rank hold ALLR as of Q2 2026.

Fidelity Investments held 13 shares of Allarity Therapeutics worth $17 as of Q2 2026.
Allarity Therapeutics was a new Fidelity Investments position in Q2 2026.
Allarity Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5513 holding.
20 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.